Epitherapeutics
Foster City
About Epitherapeutics
EpiTherapeutics is developing novel innovative cancer drugs based on epigenetics, a therapeutic area researched by renowned scientist Professor Kristian Helin and his group at Biotech Research & Innovation Centre (BRIC) at University of Copenhagen. EpiTherapeutics’ development programs are focused on enzymes involved in the regulation of transcription in cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 5,001 – 10,000
- Estimated revenue: Less than $1M
- Funding stage: M&A
- Last round: Undisclosed (Dec 2008)
- Website: epitherapeutics.dk
- Phone: 6505225696
Industries & Categories
Biotechnology, Medical
Canonical: https://fsome.com/organization/epitherapeutics-3286182 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.